TrialRheumatology (Oxford, England)2015

Second-line agents in myositis: 1-year factorial trial of additional immunosuppression in patients who have partially responded to steroids.

Fowzia Ibrahim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.